Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in RVTY — Revvity, Inc.

CIK 1166588 NEW YORK, NY

Position in RVTY

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$18,644,897
+$8,638,916 QoQ
Shares Held
212,817
+105.8% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in RVTY Over Time

Shares Held

Position Value (USD)

Derivatives in RVTY

reported options exposure · as of Mar 31, 2026
CallValue
$14,718
CallShares
168
PutValue
$150,601
PutShares
1,719

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

BNP PARIBAS ARBITRAGE, SA holds $1,383,399,743 across 39 Diagnostics & Research names. RVTY ranks #15 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RVTY

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $18,644,897 212,817
2026-03-31 $150,601 1,719
2026-03-31 $14,718 168
2025-12-31 $10,005,981 103,421
2025-09-30 $17,967,987 204,997
2025-06-30 $24,884,798 257,287
2025-03-31 $18,784,366 177,546
2024-12-31 $23,702,280 212,367
2024-09-30 $17,899,308 140,112
2024-06-30 $18,018,618 171,835
2024-03-31 $19,510,260 185,812
2023-12-31 $12,038,747 110,134
2023-09-30 $4,428,221 40,002
2023-06-30 $11,518,591 96,966
2023-03-31 $10,519,810 78,942
2022-12-31 $14,157,172 100,964
2022-09-30 $7,656,357 63,628
2022-06-30 $6,630,865 46,624
2022-03-31 $14,228,085 81,555
2021-12-31 $15,192,294 75,561
2021-09-30 $5,155,897 29,753
2021-06-30 $4,965,980 32,161
2021-03-31 $5,462,716 42,581
2020-12-31 $5,361,016 37,359
2020-09-30 $13,576,918 108,174
2020-06-30 $8,630,350 87,984
2020-03-31 $2,939,307 39,045